Health News

AMERIGROUP Corporation today announced that it will participate in the Oppenheimer 19th Annual Healthcare Conference on November 3 inNew York City.

A majority of Medicare patients with stable coronary artery disease who underwent an elective percutaneous coronary intervention did not have a recommended stress test performed to confirm the necessity of the procedure, according to a study in the Octob

High-dose vitamin B supplementation for patients with mild to moderate Alzheimer disease did not slow the rate of cognitive decline, according to a study in the October 15 issue of JAMA.

Reducing how often a patient receives amiodarone, a medication used for suppressing atrial fibrillation but which causes side effects, did not decrease the overall amount of amiodarone-related and heart disease related side effects, but did increase the

A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderat

Authors of an article in the Oct. 15 Journal of the American Medical Association are available to provide details on 'evidence-based reimbursement' as a way to reduce health care costs without diminishing quality.

Company's INS-20 Receives Regulatory Clearance to Begin Phase I Clinical Trial

The U.S. Agency for International Development is pleased to announce new grants to The Global Alliance for TB Drug Development and the International Union Against TB and Lung Disease. These grants will support late stage clinical trials for new drugs, di